4 completed, 1 recruiting. 5 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 5 | Completed 4, Recruiting 1 |
Follow Glepaglutide: new trials by email Literature Review of Glepaglutide trials Research Report on Glepaglutide
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy And Safety Evaluation of Glepaglutide in Treatment of SBS Glepaglutide, Placebo - Short Bowel Syndrome | Phase 3 | Recruiting | Zealand Pharma | 90 | 2026-02-11 | 2026-09-29 |
| The Long-term Effect on Intestinal Absorption and Safety of Treatment With Glepaglutide in Patients With Short Bowel Syndrome Glepaglutide - Short Bowel Syndrome | Phase 3 | Completed | Zealand Pharma | 12 | 2021-08-10 | 2024-11-22 |
| Evaluation of Long Term Safety and Efficacy of Glepaglutide in Treatment of SBS - Extension Trial Glepaglutide - Short Bowel Syndrome | Phase 3 | Completed | Zealand Pharma | 84 | 2021-06-16 | 2026-09-08 |
| Evaluation of Long Term Safety and Efficacy of Glepaglutide in Treatment of SBS glepaglutide - Short Bowel Syndrome | Phase 3 | Completed | Zealand Pharma | 150 | 2019-05-07 | 2026-09-08 |
| Efficacy And Safety Evaluation of Glepaglutide in Treatment of Short Bowel Syndrome (SBS) glepaglutide, Placebo - Short Bowel Syndrome | Phase 3 | Completed | Zealand Pharma | 106 | 2018-10-04 | 2025-07-17 |
Short Bowel Syndrome (5) · Digestive System Diseases (1) · Gastrointestinal Diseases (1) · Intestinal Diseases (1) · Intestinal Failure (1) · Malabsorption Syndromes (1) · Pathologic Processes (1) · Postoperative Complications (1) · Syndrome (1)
Zealand Pharma (5)
Denmark (5) · Belgium (4) · France (4) · Germany (4) · Netherlands (4) · Poland (4) · United States (4) · United Kingdom (3) · Canada (2) · Austria (1) · Finland (1) · Hungary (1) · Italy (1) · Norway (1) · Spain (1)